How long does imiquimod treatment take to work for basal cell carcinoma?

Imiquimod activates a local immune response. During the course, the area may become red, scaly, crusted, swollen, or sore before it settles. The appearance during treatment is not a reliable way to confirm that the carcinoma has been fully treated.

This option is used only for basal cell carcinomas that are suitable for topical treatment. Site, size, subtype, and whether the lesion is recurrent affect the plan. Healing can continue after the last application, and follow-up matters because a calmer surface does not replace examination of the original lesion.

Use the prescribed amount on the prescribed days, on clean and dry skin, and wash your hands after applying it. Do not cover the area unless instructed. Protect treated skin from sun, avoid scratching or removing crusts, and check before using another cream on the site.

Record applications and symptoms. Tell the treating team if pain, swelling, or skin breakdown interferes with eating, sleeping, work, or daily care. They may recommend a planned break or another measure; make that decision with them rather than altering treatment alone.

Arrange prompt advice for spreading redness with warmth, pus, severe pain, fever, extensive blistering, or an allergic-type reaction. After the course, contact the clinic if the lesion remains raised, bleeds, ulcerates, or continues changing. A follow-up examination is needed even if the area looks improved.

Ask why imiquimod is appropriate for this carcinoma, which features would make another treatment preferable, and when the site should be reviewed. Confirm the application calendar, expected inflammation, wound care, sun protection, and the signs that require an earlier assessment.